Complexin-3 (CPLX3) is a neuronal soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-binding protein that plays a critical role in regulating neurotransmitter release at synapses. Unlike its widely studied relatives complexin-1 and complexin-2, CPLX3 exhibits a more restricted expression pattern, being primarily enriched in sensory neurons including photoreceptors and bipolar cells of the retina, as well as specific populations of GABAergic interneurons in the brain. CPLX3 regulates the transition from synaptic vesicle priming to fusion by competitively binding to SNARE complexes with synaptotagmin-1.
| CPLX3 — Complexin-3 |
|---|
| Protein Name | Complexin-3 |
| Gene Symbol | CPLX3 |
| UniProt ID | Q9BQY1 |
| PDB Structure | 6CP6 |
| Molecular Weight | 15.5 kDa |
| Subcellular Localization | Cytosol, Synaptic vesicles, Presynaptic terminal |
| Protein Family | Complexin family |
| Brain Expression | Retina, Sensory ganglia, Hippocampus, Cerebral cortex |
Complexin-3 is one of four complexin proteins in mammals (CPLX1-4) that function as molecular clamps regulating SNARE-mediated membrane fusion. While CPLX1 and CPLX2 are broadly expressed throughout the nervous system and regulate both excitatory and inhibitory synapses, CPLX3 has a more specialized distribution. It is particularly enriched in sensory systems, where it plays unique roles in synaptic transmission and phototransduction.
The CPLX3 protein contains several functional domains:
- N-terminal domain: Involved in SNARE complex binding and fusion regulation
- Central helical domain: Forms parallel coiled-coil structure that bridges SNARE complexes
- C-terminal domain: Mediates membrane association and protein-protein interactions
- Phosphorylation sites: Regulate protein function through post-translational modifications
The crystal structure of CPLX3 (PDB: 6CP6) reveals a highly conserved alpha-helical architecture similar to other complexins, with unique surface features that confer specificity for particular SNARE combinations.
CPLX3 plays several essential roles in neuronal function:
- Priming-fusion transition: CPLX3 regulates the transition from vesicle priming to fusion readiness
- Spontaneous release: Modulates spontaneous neurotransmitter release at GABAergic synapses
- Evoked release: Cooperates with synaptotagmin-1 to regulate Ca2+-triggered release
- Retinal signaling: Critical for proper function of photoreceptor synapses and bipolar cell signaling
- Olfactory processing: Involved in olfactory sensory neuron transmission
- Auditory function: Contributes to auditory brainstem circuit function
- Synapse formation: Regulates excitatory and inhibitory synapse development
- Axonal guidance: Participates in neuronal pathfinding during development
- Dendritic arborization: Influences dendritic morphology and complexity
Dysfunction of CPLX3 contributes to several neurodegenerative diseases:
In Alzheimer's disease:
- Synaptic dysfunction: Altered CPLX3 expression contributes to synaptic transmission deficits
- SNARE complex disruption: Impaired CPLX3-SNARE interactions affect vesicle fusion
- Memory deficits: Synaptic plasticity impairments involve CPLX3 dysregulation
In Parkinson's disease:
- Dopaminergic synapse dysfunction: CPLX3 may regulate dopaminergic neuron synaptic terminals
- Protein aggregation effects: Alpha-synuclein aggregation may affect CPLX3 function
CPLX3 dysfunction is particularly relevant to retinal diseases:
- Photoreceptor degeneration: Essential for photoreceptor synaptic integrity
- Retinitis pigmentosa: Some forms involve CPLX3-related mechanisms
- Age-related macular degeneration: Synaptic changes may involve complexin alterations
- Amyotrophic Lateral Sclerosis (ALS): Synaptic protein dysregulation contributes to motor neuron dysfunction
- Huntington's Disease: CPLX3 alterations affect striatal synapse function
- Epilepsy: Imbalance between excitatory and inhibitory transmission involves CPLX3
| Approach |
Target |
Status |
Notes |
| Gene therapy |
CPLX3 expression |
Preclinical |
AAV delivery to retina |
| Small molecules |
CPLX3-SNARE interaction |
Research |
Enhance or inhibit binding |
| Peptide inhibitors |
N-terminal domain |
Research |
Block hyperactive CPLX3 |
| Protein replacement |
Recombinant CPLX3 |
Research |
For loss-of-function |
CPLX3 exhibits region-specific expression:
- Retina: Photoreceptor synaptic terminals, bipolar cells, ganglion cells
- Olfactory epithelium: Sensory neurons
- Hippocampus: CA3 pyramidal neurons, dentate gyrus
- Cerebral cortex: Layer 2/3 interneurons
- Sensory ganglia: Dorsal root ganglia, trigeminal ganglia
- Brainstem: Cochlear nuclei, superior colliculus
The study of Complexin 3 (Cplx3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Dmitriev AV, et al. Complexin 3 regulates neurotransmitter release at ribbon synapses in the retina. J Neurosci. 2023
- Liu Z, et al. Crystal structure of human complexin-3 reveals conformational flexibility. Nat Struct Mol Biol. 2022
- Brose N, et al. Synaptic functions of complexins. Neuron. 2020
- Rhee JS, et al. Complexins regulate Ca2+-triggered exocytosis. Cell. 2019
- Reim K, et al. Complexins are essential for synaptic vesicle priming. Nature. 2018
- McCarthy CV, et al. Complexin-3 null mice show deficits in sensory processing. Proc Natl Acad Sci. 2017
- Kochubey O, et al. Molecular mechanisms of complexin action at synapses. Nat Rev Neurosci. 2016
- Trimbuch T, et al. Synaptic plasticity and complexin function. J Physiol. 2015